These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6767648)

  • 1. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
    Seboldt H
    Fortschr Med; 1980 Feb; 98(7):257-60. PubMed ID: 6767648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of arterial-circulation disorders in the legs. Muscle-ergometric studies under the effects of butalamine hydrochloride in a double-blind trial].
    Bopp J
    Fortschr Med; 1976 Apr; 94(12):725-7. PubMed ID: 823084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug therapy of chronic arterial occlusive diseases of the lower extremities with butalamine-HCl].
    Kling H
    Fortschr Med; 1979 May; 97(19):926-8. PubMed ID: 109382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
    Dal Lago A; De Martini D; Flore R; Gaetani E; Gasbarrini A; Gerardino L; Pola R; Santoliquido A; Serricchio M; Tondi P; Nolfe G
    Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Naftidrofuryl in arterial occlusive disease. Controlled multicenter double-blind study with oral administration].
    Maass U; Amberger HG; Böhme H; Diehm C; Dimroth H; Heidrich H; Heinrich F; Hirche H; Mörl H; Müller-Bühl U
    Dtsch Med Wochenschr; 1984 May; 109(19):745-50. PubMed ID: 6373217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification].
    Branchereau A; Rouffy J
    J Mal Vasc; 1995; 20(1):21-7. PubMed ID: 7745355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy of arterial diseases. A study with Trental 400].
    Tannenberg G
    Fortschr Med; 1980 Dec; 98(45):1795-8. PubMed ID: 7461576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
    Canonico V; Ammaturo V; Guarini P; Tedeschi C; Nunziata G; Nappi A; Forgione L; Rengo F
    Minerva Cardioangiol; 1991 Mar; 39(3):75-80. PubMed ID: 1881558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication].
    Rudofsky G
    Wien Klin Wochenschr; 1988 Jul; 100(14):484-8. PubMed ID: 3062906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
    Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency.
    Bauer U
    Arzneimittelforschung; 1984; 34(6):716-20. PubMed ID: 6386008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Xenon-133 muscle clearance before and after butalamine hydrochloride. Results of a double blind test].
    Zeitler E
    Fortschr Med; 1976 Dec; 94(34):2055-8. PubMed ID: 826469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Padma-28, a herbal preparation, increases walking distance in patients with intermittent claudication].
    Drabaek H; Mehlsen J; Petersen JR; Himmelstrup H; Hansen KF
    Ugeskr Laeger; 1994 Oct; 156(42):6207-9. PubMed ID: 7998359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Active therapeutic exercises in combination with vasoactive drug in intermittent claudication (author's transl)].
    Krause D; Dittmar K
    MMW Munch Med Wochenschr; 1978 Jan; 120(2-3):69-72. PubMed ID: 414129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adrevil improves the peripheral blood flow. Results of a study using the 133-Xe muscle clearance method on lower limbs].
    Klemm J
    Fortschr Med; 1977 Jul; 95(28):1791-4. PubMed ID: 410717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.
    Brass EP; Anthony R; Cobb FR; Koda I; Jiao J; Hiatt WR
    J Am Coll Cardiol; 2006 Dec; 48(12):2539-45. PubMed ID: 17174195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
    Battke K; Buchwalsky R; Barmeyer J; Hoffmann G; Reindell H
    Fortschr Med; 1978 Jul; 96(26-27):1381-6. PubMed ID: 669532
    [No Abstract]   [Full Text] [Related]  

  • 19. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG; Edwin Langbein W; Orebaugh C; Bammert C; Hanson K; Reda D; Edwards LC; Littooy FN
    Med Sci Sports Exerc; 2003 Mar; 35(3):384-93. PubMed ID: 12618567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.